U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06416735) titled 'Natriuretic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant' on Sept. 4, 2023.

Brief Summary: The study is a non-pharmacological interventional, single-center, national, non-randomised, comparative and open label.

Study Type: Interventional

Condition: * Hypertension Essential

* Salt Excess

* Genetic Hypertension

Intervention: Drug: Amiloride

administration of a single dose of 5 or 10 mg of Amiloride (based on body weight) After oral intake of the drug, the increase in sodium in the urine ends within 8 hours

Recruitment Status: Completed

Published by HT Digital Content Services with permissio...